Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
WS 01 - IASLC Supporting the Implementation of Quality Assured Global CT Screening Workshop (By Invitation Only)
- 08:30 - 21:00
- 10/14/2017
- Location: F203 (Annex Hall)
- Type: Workshop
- Track: Radiology/Staging/Screening
- > View Program / Invitation (PDF)
-
+
WS 01.16 - Session 3: Added Value to Lung Cancer CT Screening Programs
11:30 - 11:30 | Presenter: Kwun M Fong, Nir Peled
- Abstract
No abstract available for this presentation
-
+
WS 02 - IASLC Symposium on the Advances in Lung Cancer CT Screening (Ticketed Session SOLD OUT)
- 09:00 - 18:15
- 10/14/2017
- Location: F201 + F202 (Annex Hall)
- Type: Symposium
- Track: Radiology/Staging/Screening
- > View Program / Invitation (PDF)
-
+
WS 02.11 - Session 3: Early Detection Biomarkers
14:00 - 14:00 | Presenter: Luis M Montuenga, Nir Peled
- Abstract
No abstract available for this presentation
-
+
WS 02.13 - New Approaches to Interventional Pulmonology for Lung Cancer Screening
14:30 - 15:00 | Presenter: Nir Peled
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-039 - Survival Impact of Next-Generation Sequencing in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): A. Belilovski Rozenblum, M. Ilouze, L.C. Roisman, Elizabeth Dudnik, A. Zer, Nir Peled
- Abstract
Loading...
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.06 - BRAF Mutant NSCLC: Correlation with PD-L1 Expression,TMB, MSI and Response to ICPi and Anti-BRAF Therapy
11:35 - 11:40 | Presenter: Elizabeth Dudnik | Author(s): Nir Peled, M. Wollner, Amir Onn, A. Agbareya, H. Nechushtan, T. Kuznetsov, L.C. Roisman, A. Belilovski Rozenblum, Smadar Geva, A. Zer, Jair Bar
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-048 - Immunotherapy vs. Targeted Therapy - Who Wins? A Case Series
09:30 - 09:30 | Presenter: Inbar Finkel | Author(s): Nir Peled
- Abstract
Loading...
-
+
MS 13 - How to Deal with CNS Metastases
- 11:00 - 12:30
- 10/17/2017
- Location: Room 502
- Type: Mini Symposium
- Track: Advanced NSCLC
- Moderators:Martin Schuler, Nir Peled
-
+
MS 13.01 - Strategic Approach to CNS Metastasis
11:00 - 11:15 | Presenter: Maurice Pérol
- Abstract
Loading... -
+
MS 13.02 - SBRT vs. WBRT
11:15 - 11:30 | Presenter: Paul Van Houtte | Author(s): D. Devriendt
- Abstract
Loading... -
+
MS 13.03 - Target Therapy for ALK/ROS1 + NSCLC with CNS Metastasis
11:30 - 11:45 | Presenter: Alice Shaw
- Abstract
No abstract available for this presentation
-
+
MS 13.04 - The Role of Chemotherapy in the Management of CNS Metastasis
11:45 - 12:00 | Presenter: Chong-Kin Liam
- Abstract
Loading... -
+
MS 13.05 - Targeted Therapy for EGFR Positive Mutant NSCLC with CNS Metastasis
12:00 - 12:15 | Presenter: Myung-Ju Ahn
- Abstract
Loading... -
+
MS 13.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MA 18 - Global Tobacco Control and Epidemiology II
- 15:45 - 17:30
- 10/17/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
- Moderators:H. Kawai, Christian Klaus Manegold
-
+
MA 18.11 - High Incidence of Lung Cancer in Early Stage TCC Patients
16:55 - 17:00 | Presenter: Yaakov Tolwin | Author(s): I. Nardi-Agmon, E. Rosenbaum, Nir Peled
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-056 - Intracranial Activity of Osimertinib in Naïve EGFRm T790M(-)And Treated EGFRm T790M(+) NSCLC Patients with Asymptomatic Brain Metastases
09:30 - 09:30 | Presenter: Nir Peled | Author(s): H. Nechushtan, M. Ilouze, Elizabeth Dudnik, E. Inbar
- Abstract
Loading... -
+
P3.01-060 - The Clinical Utility of ctDNA Gene Analysis in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): A. Belilovski Rozenblum, M. Ilouze, L.C. Roisman, Elizabeth Dudnik, A. Zer, T. Twito, A. Dvir, L. Soussan-Gutman, R.B. Lanman, Nir Peled
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P3.02-096 - The Interaction Between Mast Cells and Lung Cancer Cells Through Extracellular Vesicles
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): Y. Gorzalczany, L.C. Roisman, M. Ilouze, R. Shemesh, R. Sagi-Eisenberg, Nir Peled
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-022 - Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement but Better Survival
09:30 - 09:30 | Presenter: Nir Peled | Author(s): A.M. Suidan, M. Ilouze
- Abstract
Loading...
